Search results for VEGFD antibody
![PE Anti-VEGFD antibody [EPR8457] Brand Logo](https://file.buyantibody.com/public/brand/20260608/Abcam.jpg "Click to View PE Anti-VEGFD antibody [EPR8457] Product Detail")
PE Anti-VEGFD antibody [EPR8457], Abcam, AB306182
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
Antibody Labelling, Target Binding Affinity, ICC/IF, IHC-P, Flow Cyt (Intra)
Conjugation
PE
APC Anti-VEGFD antibody [EPR8457], Abcam, AB306183
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
ICC/IF, Antibody Labelling, Flow Cyt (Intra), IHC-P, Target Binding Affinity
Conjugation
APC
Biotin Anti-VEGFD antibody [EPR8457], Abcam, AB204679
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .
Host
Rabbit
Reactivity
Human, Human, Mouse, Rat
Applications
WB, IHC-P
Conjugation
Biotin
VEGFD Antibody (YA2385)(PBS only), MedChemexpress, HY-P82640A
VEGFD Antibody (YA2385) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to VEGFD.
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
WB, IHC-F, IHC-P, ICC/IF
Conjugation
Non-conjugated
HRP Anti-VEGFD antibody [EPR8457], Abcam, AB306184
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
Antibody Labelling, Target Binding Affinity, IHC-P, WB
Conjugation
HRP
Anti-VEGFD antibody [EPR8457] - BSA and Azide free, Abcam, AB232447
ab232447 is the carrier-free version of ab155288 . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Conjugation ready Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. Compatibility This product is compatible with the Maxpar ® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar ® is a trademark of Fluidigm Canada Inc.
Host
Rabbit
Reactivity
Mouse, Rat, Human
Applications
ICC/IF, WB, IHC-P, Flow Cyt (Intra)
Conjugation
Vascular endothelial growth factor D (VEGFD) Antibody, Abbexa, abx329995
FIGF Antibody is a Rabbit Polyclonal against FIGF.
Host
Rabbit
Reactivity
Human, Mouse, Rat, Monkey
Applications
ELISA, WB, IHC
Conjugation
Unconjugated
Alexa Fluor® 647 Anti-VEGFD antibody [EPR8457], Abcam, AB310023
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human, Mouse, Rat
Applications
IHC-P, Antibody Labelling, Target Binding Affinity, ICC/IF, Flow Cyt (Intra)
Conjugation
Alexa Fluor® 647
Vascular Endothelial Growth Factor D / FIGF (VEGFD) Antibody, Abbexa, abx178848
This product is currently in development. The lead time for this product may be several months. Please contact us at [email protected] for an updated lead time before purchasing this product. Vascular Endothelial Growth Factor D / FIGF (VEGFD) Antibody is a Rabbit Polyclonal antibody against Vascular Endothelial Growth Factor D / FIGF (VEGFD).
Host
Rabbit
Reactivity
Rat
Applications
WB, IHC, IF/ICC
Conjugation
Unconjugated
Vascular Endothelial Growth Factor D / FIGF (VEGFD) Antibody, Abbexa, abx110344
VEGFD Antibody is a Rabbit Polyclonal antibody against VEGFD. Recombinant Human VEGFD ProteinGrowth Factor Active In Angiogenesis, Lymphangiogenesis And Endothelial Cell Growth, Stimulating Their ProlifeRation And MigRation And Also Has Effects On The Permeability Of Blood VesselsMay Function In The Formation Of The Venous And Lymphatic Vascular Systems During Embryogenesis, And Also In The Maintenance Of Differentiated Lymphatic Endothelium In AdultsBinds And Activates Vegfr-2 (Kdr/Flk1) And Vegfr-3 (Flt4) Receptors.
Host
Rabbit
Reactivity
Human
Applications
ELISA, IHC
Conjugation
Unconjugated
Please provide the required information below so that we can quickly source your products.